Royal Bank of Canada
TNYA icon

Royal Bank of Canada’s Tenaya Therapeutics TNYA Stock Holding History

Royal Bank of Canada’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3K Buy
5,043
+1,338
+36% +$987 ﹤0.01% 6624
2025
Q4 		$3K Sell
3,705
-260,657
-99% -$354K ﹤0.01% 6854
2025
Q3 		$428K Sell
264,362
-30,012
-10% -$30.2K ﹤0.01% 4602
2025
Q2 		$180K Buy
294,374
+291,319
+9,536% +$148K ﹤0.01% 5242
2025
Q1 		$1K Sell
3,055
-2,287
-43% -$2.26K ﹤0.01% 6720
2024
Q4 		$8K Sell
5,342
-2,379
-31% -$5.33K ﹤0.01% 6418
2024
Q3 		$15K Buy
7,721
+2,533
+49% +$7.15K ﹤0.01% 6216
2024
Q2 		$16K Buy
5,188
+4,126
+389% +$17K ﹤0.01% 6166
2024
Q1 		$5K Sell
1,062
-14,848
-93% -$71K ﹤0.01% 6464
2023
Q4 		$51K Buy
15,910
+7,971
+100% +$17.2K ﹤0.01% 5987
2023
Q3 		$21K Buy
7,939
+3,163
+66% +$13.2K ﹤0.01% 6174
2023
Q2 		$28K Buy
4,776
+2,344
+96% +$13.6K ﹤0.01% 6048
2023
Q1 		$7K Sell
2,432
-2,641
-52% -$7.42K ﹤0.01% 6466
2022
Q4 		$10K Buy
5,073
+4,732
+1,388% +$11.6K ﹤0.01% 6553
2022
Q3 		$1K Buy
341
+184
+117% +$859 ﹤0.01% 7275
2022
Q2 		$1K Sell
157
-1,601
-91% -$13K ﹤0.01% 7208
2022
Q1 		$21K Sell
1,758
-1,145
-39% -$13.9K ﹤0.01% 6586
2021
Q4 		$55K Buy
2,903
+1,213
+72% +$26.4K ﹤0.01% 6329
2021
Q3 		$35K Buy
+1,690
New +$36.3K ﹤0.01% 6370

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's TNYA Position: Q1 2026 in Review

Royal Bank of Canada increased its Tenaya Therapeutics (TNYA) stake by 36% in Q1 2026, buying an estimated $987 and bringing the position to 5,043 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #6624.

Royal Bank of Canada first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $428K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Royal Bank of Canada held 5,043 shares of Tenaya Therapeutics worth $3K as of Q1 2026.
  • Royal Bank of Canada bought 1,338 Tenaya Therapeutics shares in Q1 2026, an estimated $987.
  • Tenaya Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6624 holding.
  • Royal Bank of Canada first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Tenaya Therapeutics position peaked at $428K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.